The ethics of wasting the donor's gift of buffy coat

Vox Sanguinis

Volumn 100, Issue 2, 2011, Pages 256-257

  Vamvakas, E C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

BLEEDING; BLOOD BUFFY COAT; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CRYOPRECIPITATE; ERYTHROCYTE; HEALTH CARE SYSTEM; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; RECIPIENT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

BLOOD DONORS; BLOOD PLATELETS; HUMANS; PLATELET ACTIVATION; PLATELET TRANSFUSION; PLATELETPHERESIS;

EID: 78651335114     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01405.x     Document Type: Letter

References (7)

1. Schrezenmeier H, Seifried E: Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 2010; 99:1-15
2. Whitaker BI, Green J, King MR, et al. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington DC, Department of Health and Human Services. Available at.
3. Popovsky MA: Multicomponent apheresis blood collections in the United States: Current status and future directions. Transfus Apher Sci 2005; 32:299-304
4. Zingsem J: Multicomponent apheresis. ISBT Science Series 2010; 5:83-87
5. Kamel H, Tomasulo P, Bravo M, et al. Delayed adverse reactions to blood donation. Transfusion 2010; 50:556-565
6. Brooks JP: The rights of blood recipients should supersede any asserted rights of blood donors. Vox Sang 2004; 87:280-286
7. Vamvakas EC: The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets. Clin Lab 2010; 56:263-279